APOHA LIMITED

Active London

Research and experimental development on biotechnology

11 employees website.com
Information technology, telecommunications and data Research and experimental development on biotechnology
A

APOHA LIMITED

Research and experimental development on biotechnology

Founded 19 Apr 2021 Active London, United Kingdom 11 employees website.com
Information technology, telecommunications and data Research and experimental development on biotechnology
Accounts Submitted 16 Aug 2024 Next due 30 Apr 2026 10 days remaining
Confirmation Submitted 22 Apr 2025 Next due 25 Apr 2026 5 days remaining
Net assets £6M £7M 2024 year on year
Total assets £6M £6M 2024 year on year
Total Liabilities £68K £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Nw Works Units 8 & 9 135 Salusbury Rd London NW6 6RJ United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for APOHA LIMITED (13344316), an active information technology, telecommunications and data company based in London, United Kingdom. Incorporated 19 Apr 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£5.95M

Increased by £5.60M (+1578%)

Net Assets

£6.25M

Increased by £6.82M (+1182%)

Total Liabilities

£68.25k

Decreased by £1.05M (-94%)

Turnover

N/A

Employees

11

Increased by 3 (+38%)

Debt Ratio

1%

Decreased by 206 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 2

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 2Sept 2023Seed
Investor 3Sept 2023Seed
Investor 4Sept 2023Seed

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 5,822,646 Shares £7.87m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Jan 202459,985£101k£1.692
3 Oct 20231,820,586£1.10m£0.604
3 Oct 20233,942,075£6.67m£1.692

Officers

Officers

3 active
Status
Anshika SrivastavaDirectorIndianEngland4011 May 2021Active
Michael SidlerDirectorSwissSwitzerland573 Oct 2023Active
Shamit ShrivastavaDirectorBritishEngland4019 Apr 2021Active

Shareholders

Shareholders (19)

Shamit Shrivastava
31.7%
5,023,500
Anshika Srivastava
30.5%
4,826,500

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Anshika Srivastava

Indian

Active
Notified 19 Apr 2021
Residence England
DOB November 1985
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Shamit Shrivastava

British

Active
Notified 19 Apr 2021
Residence England
DOB June 1985
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Apr 2026OfficersAppointment of Mr Raffi Kamber as director on 2026-03-25
2 Apr 2026CapitalAllotment of shares (GBP 211.32723) on 2026-03-25
23 Mar 2026IncorporationMemorandum Articles
23 Mar 2026ResolutionResolutions
4 Sept 2025OfficersChange to director Dr Michael Sidler on 2025-09-01
8 Apr 2026 Officers

Appointment of Mr Raffi Kamber as director on 2026-03-25

2 Apr 2026 Capital

Allotment of shares (GBP 211.32723) on 2026-03-25

23 Mar 2026 Incorporation

Memorandum Articles

23 Mar 2026 Resolution

Resolutions

4 Sept 2025 Officers

Change to director Dr Michael Sidler on 2025-09-01

Recent Activity

Latest Activity

Appointment of Mr Raffi Kamber as director on 2026-03-25

1 weeks ago on 8 Apr 2026

Allotment of shares (GBP 211.32723) on 2026-03-25

2 weeks ago on 2 Apr 2026

Memorandum Articles

3 weeks ago on 23 Mar 2026

Resolutions

3 weeks ago on 23 Mar 2026

Change to director Dr Michael Sidler on 2025-09-01

7 months ago on 4 Sept 2025